sb 239063 has been researched along with ovalbumin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Jiang, H; Liu, J; Liu, L; Zhang, J | 1 |
| Jeon, MS; Kim, SR; Lee, KS; Lee, YC; Park, SJ | 1 |
| Bao, A; Chung, KF; Li, F; Liang, L; Zhang, M; Zhou, X | 1 |
3 other study(ies) available for sb 239063 and ovalbumin
| Article | Year |
|---|---|
p38 MAPK regulates Th2 cytokines release in PBMCs in allergic rhinitis rats.
Topics: Animals; Cytokines; Female; Imidazoles; Interleukin-4; Interleukin-5; Leukocytes, Mononuclear; Male; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Rhinitis, Allergic, Seasonal; RNA, Messenger; Th2 Cells | 2010 |
Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease.
Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Endothelial Growth Factors; Female; Imidazoles; Immunoglobulin E; Mice; Mice, Inbred C57BL; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Protein Kinase Inhibitors; Pyrimidines; Vascular Endothelial Growth Factor A | 2012 |
Activation of p38 mitogen-activated protein kinase in ovalbumin and ozone-induced mouse model of asthma.
Topics: Adrenal Cortex Hormones; Animals; Asthma; Disease Models, Animal; Drug Therapy, Combination; Dual Specificity Phosphatase 1; Enzyme Inhibitors; HSP27 Heat-Shock Proteins; Imidazoles; Lung; Male; Mice; Mice, Inbred C57BL; Ovalbumin; Ozone; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Signal Transduction; Treatment Outcome | 2013 |